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The success of endodontic treatment involves an intricate blend of chemical and mechanical debridement techniques. However, in about 10%--15% of treated cases, failure can be attributed to the emergence of uncontrolled symptoms and their long-term persistence in the root canal complexities.\[[@ref1]\] Endodontic surgery is implicated when an endodontically treated tooth succumbs to a periradicular pathosis, and nonsurgical endodontic retreatment is not feasible. The aforesaid statement is supported by claims put forward by Natkin *et al*. 1984 and Nair *et al*. 1998, wherein they assessed the radiographic size of lesions and finally concluded that if the lesion does not involve the apex with an intact epithelial lining, it may not heal nonsurgically.\[[@ref2]\] Over the years, although the list of indications for endodontic surgery has diminished, there however exists definite case reports wherein the tooth could not have been retained without a surgical approach.

The concept of surgical endodontics dates back to 1500 years from the pioneering work initiated by Aetius, based on incision and drainage\[[@ref3]\] and has been a major breakthrough ever since. Surgical debridement and resective techniques have been the traditional approaches practiced to enhance periapical healing thereby seizing disease progression.

The incorporation of autologous platelet concentrates in surgical endodontic procedures holds unquestionable promise when dealing with large periapical lesions.\[[@ref4]\] Nevertheless, several pitfalls concerning the use of first-generation platelet concentrates are one too many such as the risk of coagulopathies, use of anticoagulants, handling properties, cost and also entails tedious two-step centrifugation and purification process.\[[@ref5]\] In order to overcome the aforementioned limitations, concentrated growth factor (CGF), touted as the second-generation platelet concentrate, introduced by Sacco *et al*., 2006, not only has been suggested as an ideal biomaterial but is also claimed to be better than platelet-rich fibrin (PRF) due to its richer and thicker growth factor content that promotes cell proliferation, migration and also stimulates tissue remodeling at a faster rate.\[[@ref6]\] On another note, CGF has been extensively used for implant surgeries and sinus ridge augmentation procedures in the recent past, exhibiting favorable results.\[[@ref7]\]

Bioresorbable demineralized bone material has been widely used in varied clinical scenarios, prominently in bony defects, and extensive lesions with histological evidence of regeneration of new bone and its supporting tissues. Bone allograft induces pluripotent stem cells to differentiate into osteoblasts which in turn promotes cellular differentiation and bone formation through osteoinduction.\[[@ref8]\] The use of an osseograft combined with CGF has numerous advantages owing to the formation of sticky bone. The product thus formed can be molded, prevent both macro and micro movements, also the network is proven to contain platelets and growth factors thereby contributing to accelerated soft-tissue healing and bone regeneration. Furthermore, the fibrin interconnection prevents the ingrowth of soft tissue into the bone graft as well.\[[@ref9]\] A thorough search of the literature disclosed the absence of any publication with reference to the use of sticky bone in endodontic surgical procedures, thus highlighting the uniqueness of this case report in that regard.
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=======================================

A 26-year-old male patient reported to the Department of Oral and Maxillofacial surgery with a chief complaint of shift in the normal position of teeth in the right mandibular back tooth region. Following biopsy with respect to the said tooth region, i.e., 43, 44, 45, a provisional diagnosis of odontogenic keratocyst was made. The patient was then referred for endodontic opinion and further management regarding the same before performing elective surgery.

The medical and dental history was non-contributory. Intraoral clinical examination revealed pathological migration of 43 with no debilitating symptoms \[[Figure 1a](#F1){ref-type="fig"}\]. The electric pulp testing (Gentle Pulse™ Pulp Vitality Tester, Parkell, USA) showed a negative response on 43, 44, 45 when compared with the control teeth. On radiographic examination (VistaScan Mini, UK), periapical radiolucency was evident in 43, 44, 45 \[[Figure 2a](#F2){ref-type="fig"}\]. Cone-beam computed tomography (CBCT) (Dentsply Sirona, Orthophos XG 3D) was taken at standardized settings (90 kV, 6 mA, 5 cm × 5.5 cm, 160 μm, 14 s) to assess the information on periapical lesion extent and the proximity to anatomic structures. The preoperative measurements of the lesion extent were viewed in different planes; the tangential section measured 14.39 mm × 9.42 mm; cross-sectional measured 14.77 mm × 8.46 mm and axial section measured 12.14 mm × 6.52 mm \[Figure [2c](#F2){ref-type="fig"}--[g](#F2){ref-type="fig"}\].

![Preoperative clinical and surgical procedure. Preoperative clinical photograph showing drifted 43, 44, 45 (a). Flap elevation and cystic enucleation, apicoectomy, and retrograde filling (b). Placement of concentrated growth factor cystic space (c). Placement of sticky bone (d). Placement of concentrated growth factor membrane (e). Sutures placed (f)](AMS-10-246-g001){#F1}

![Preoperative radiographic images-intraoral periapical and cone-beam computed tomography images. Preoperative intraoral periapical showing periapical lesion involving the apices of 43, 44, 45 (a). Postoperative intraoral periapical showing healing (b). Preoperative cone-beam computed tomography image showing the extent of lesion in cross-sectional slice (c). Postoperative cone-beam computed tomography image showing the extent of lesion in cross-sectional slice (d). Preoperative cone-beam computed tomography showing the lesion in tangential slice (e). Postoperative cone-beam computed tomography showing the lesion in tangential slice (f). Preoperative cone-beam computed tomography showing the lesion in axial section (g). Postoperative cone-beam computed tomography showing the lesion in axial section (h)](AMS-10-246-g002){#F2}

According to the CBCT-periapical index scoring system, the lesion for the present case was graded as 5E. On the basis of the above findings, the diagnosis of pulpal necrosis with a chronic apical abscess in 43, 44, 45 was made. Root canal therapy was proposed as the first line of treatment in relation to 43, 44, 45 prior to periapical surgery followed by the positioning of a combination of CGF and bone graft (sticky bone) over the defective site.

On the first visit, informed consent was obtained from the patient, local anesthesia was administered (2% lignocaine with 1:200,000 dilution adrenaline, Neon laboratories LTD), teeth were isolated with rubber dam, followed by access cavity preparation with endo access bur (DENTSPLY Mallifer, Switzerland). Working length was determined using an electronic apex locator (Propex Pixi, DENTSPLY Mallifer, Switzerland) and confirmed radiographically. The irrigation protocol included thorough rinsing with copious amounts of 3% sodium hypochlorite (VIP, Vensons, India), intermediate flushing with 0.9% saline (acuLIFE, India), and 17% EDTA (Canalarge, Ammdent, India) as the final irrigant. Calcium hydroxide (RC Cal, Prime dental products, India) was placed as intracanal medicament for 3 weeks. Obturation was carried out in 43, 44, 45 \[[Figure 2b](#F2){ref-type="fig"}\].

A state of unconsciousness was induced by general anesthesia advocating the use of propofol maintained by isoflurane volatile liquid and atracurium as muscle relaxant. Nitrous oxide analgesia was administered followed by neostigmine as a reversal agent. Full-thickness mucoperiosteal flap was elevated with two vertical incisions, complete curettage was carried out, followed by apicectomy and retrograde filling with MTA in 43, 44, 45 \[[Figure 1b](#F1){ref-type="fig"}\]. Later, the surgical site was prepared for the placement of a combination of CGF with osseograft followed by CGF membrane \[Figure [1c](#F1){ref-type="fig"} and [d](#F1){ref-type="fig"}\].

The present case necessitated the use of two 10 mL disposable nonanticoagulant tubes and a centrifuge machine (MEDIFUGE, Silfradentsrl, S. Sofia, Italy). A volume of 20 mL of intravenous blood was drawn from the patient, transferred to centrifuge tubes, accelerated for 30 s; centrifuged at 2700 rpm for 2 min, 2400 rpm for 4 min, 2700 rpm for 4 min, and 3000 rpm for 3 min; decelerated for 36 s to stop. At the end of the automated pre-programmed cycle, the centrifuge tube encompassed a concoction of four different layers; the uppermost or the 1^st^ layer contained serum, the 2^nd^ layer was composed of a fibrin buffy coat, the 3^rd^ layer constituted the much-needed growth factors, finally, the lowermost or the 4^th^ layer was occupied by the red blood cells. The fibrin gel accommodating the CGF was separated from the red blood cells, dispensed onto a metal storage box, compressed using a metal cover to procure the CGF membrane which was effectively used as a substitute for GTR \[[Figure 1e](#F1){ref-type="fig"}\]. Osseograft was mixed with the fibrin gel to form sticky bone. Subsequent to placement of sticky bone and CGF membrane over the defective site, the flap was approximated with 3-0 vicryl sutures (Ethicon Inc., Piscataway, USA) \[[Figure 1f](#F1){ref-type="fig"}\]. Postoperative instructions were given to the patient, following which medications were prescribed.

Follow-up {#sec2-1}
---------

Suture removal was done after a week. No adverse events were reported, at 1 year follow-up, intraoral periapical radiograph \[[Figure 3](#F3){ref-type="fig"}\], and CBCT revealed a thorough healing at 43, 44, 45 region with bone regeneration at the defective site \[Figure [2d](#F2){ref-type="fig"}, [f](#F2){ref-type="fig"} and [h](#F2){ref-type="fig"}\]. Livewire segmentation using OSIRIX Version 9.5 (PIXMEO, Geneva, Switzerland) was done to delineate the lesion from healthy bone. Pre- and post-operative volume calculations were 1.0798 cm^3^ and 0.2265 cm^3^, respectively \[Figure [4a](#F4){ref-type="fig"} and [b](#F4){ref-type="fig"}\]. The lesion reduction size was found to be 79%.

![1 and 2 years\' follow radiographs showing 90% healing of the periapical lesion](AMS-10-246-g003){#F3}

![Preoperative and postoperative volume calculations to delineate the lesion from healthy bone. (a and b) Preoperative and postoperative volume calculations, respectively](AMS-10-246-g004){#F4}
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The present case report focuses on the use of CGF combined with bone grafts as a biomaterial that conforms to achieving repair and regeneration following periapical surgery. CGF was prepared in a pre-programmed device, the fibrin rich blocks thus formed were larger and denser encasing innumerable growth factors.\[[@ref10]\]

The extensive use of sticky bone in cases of sinus ridge augmentation procedures yielding clinically positive results is discussed in [Table 1](#T1){ref-type="table"}.

###### 

Surgical application of CGF in combination with bone graft -- Review of literature

  Author and year                 Number of cases and procedure   CGF preparation   CGF and bone graft                  Follow-up                     Healing assessment method                            Results
  ------------------------------- ------------------------------- ----------------- ----------------------------------- ----------------------------- ---------------------------------------------------- --------------------------------------------------------------------
  Torrisi *et al*., 2011          8, sinus augmentation           Medifuge          CGF and Bio-Oss                     5 months                      OPG and histology                                    New bone formation
  Gheno *et al*., 2014            1, Sinus augmentation           Medifuge          FRB and Xenograft                   4 months                      Clinical evaluation and histomorphometric analysis   Presence of NB, together with n-MT and RBG (12 months)
  Georgakopoul *et al*., 2014     1, Sinus augmentation           Medifuge          FRB and allograft                   8 months                      OPG, CBCT, Osstell readings and stability values     ISQ values of 61-69 with new bone formation around implants
  Dong Seok sohn *et al*., 2015   3, ridge augmentation           Medifuge          FRB, sticky bone and CGF Membrane   6 months                      Histology, OPG, CBCT                                 Favorable ridge augmentation
  Chen *et al*., 2016             16, Sinus floor elevation       Medifuge          FRB, BioOss, CGF membrane           2 weeks, 1, 3, 6, 12 months   Clinical evaluation and CBCT                         Predictable clinical result
  Qiao *et al*., 2016             31, Intrabony defects           Medifuge          FRB, BioOss and CGF membrane        Baseline, 1 year              Clinical evaluation                                  CGF showed higher clinical positive results compared to PRP
  Gokmenoglu *et al*., 2016       4, lateral cyst                 Medifuge          FRB, Xenografts, CGF membrane       Baseline, 3 months            Clinical and radiographic                            Positive clinical impact
  Doan *et al*., 2017             2, cystic lesions               Medifuge          CGF, Bio Oss, CGF membrane          1, 7 days; 1, 3 months        Clinically evaluation, Radiography                   Mphi laser reduced postoperative pain and yielded wound healing
  Ying *et al*., 2017             1, bone defect                  Medifuge          CGF membrane and autologous bone    3, 6, 12 months               Clinical evaluation and CBCT                         Clinically positive results with bone regeneration evident in CBCT

CGF: Concentrated growth factor, CBCT: Cone-beam computed tomography, PRP: Platelet-rich plasma, FRB: Fibrin rich block, NB: New bone, ISQ: Implant stability quotient, n-MT: Non-mineralized tissue, OPG: Orthopantomogram, RBG: Residual bone graft

In the literature, two case reports have described the utilization of sticky bone in the treatment of bony defects at which point satisfactory clinical impact was evident in addition to favorable ridge augmentation after 1 year by virtue of lack of macro and micro movements.\[[@ref5][@ref7]\] In one case report, there was a lack of evidence on the usage of Medifuge required for CGF preparation, whereas the other laid emphasis on the use of sticky bone along with Mphi laser. However, both did not accentuate an individual parameter. The present case report, on the other hand, is the first of its kind wherein a Medifuge was used as per the required specifications apart from implementing sticky bone in endodontic surgery.

CGF is a distinctive autologous platelet concentrate eminently rich in growth factors, namely transforming growth factor-beta 1 (TGF-ß1) and vasoendothelial growth factor (VEGF). While TGF-ß1 stimulates expression of bone morphogenic proteins, curtails matrix metalloproteinases, and other enzymes to further incite differentiation of osteoblastic cells,\[[@ref11]\] VEGF at the same time induces endothelial cell migration and proliferation eventually leading to hyperpermeability of blood vessels.\[[@ref12]\] Moreover, in a comparative study, Park *et al*. reported an escalated level of growth factors, notably VEGF in CGF as opposed to PRF.\[[@ref13]\]

Osseograft used in the present case being a demineralized dried xenograft elicits both osteoinductive and osteoconductive properties. Bone grafts containing particle size of 125--1000 μm have greater osteogenic potential. Shortly, after the initial 2 min of centrifugation, autologous fibrin glue was obtained which when combined with particulate bone powder and allowed to polymerize for 5--10 min, led to the acquisition of sticky bone with an inherent capability to not migrate onto the interlinked fibrin matrix.

The present case was graded as 5E, denoting the diameter of periapical radiolucency to be more than 8 mm along with the expansion of periapical cortical bone.\[[@ref14]\] However, at 1 year follow-up, CBCT scan with a small field of view, well within the guidelines proposed by the European Society of Endodontology, AAE, and AAOMR joint position statement,\[[@ref15]\] helped to determine the extent of healing of the lesion.

All things considered, the present case report showcased exceptional results in terms of periapical healing and is probably ascribable to the inclusion of a dynamic combination of CGF and bone grafts to form sticky bone as a means to induce a rapid repair and regenerative process.

C[ONCLUSION]{.smallcaps} {#sec1-4}
========================

In our previous report of two cases, CGF was effectually employed singly as a scaffolding medium, eliciting unprecedented response in terms of periapical healing. However, the present case focuses on a conspicuous coalescence of CGF and bone graft (sticky bone) to intercept a large periapical bony lesion. Considering the pragmatism and relative practicality of this case in conjuncture with the available evidence on the use of sticky bone in varied specialties, CGF and bone grafts in unison can be utilized with great effect so as to yield resounding success to stem the repair and regenerative process. The present case report holds limitations on the grounds that histological evaluation of the bony defect is required to further substantiate the role of sticky bone in regeneration on a long-term basis.
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